Last edition
News about "Establishment Inspection Report (EIR) "
Lupin Receives EIR from US FDA for its Pithampur Unit-3 Facility
Following an inspection in July 2025, Lupin received the USFDA’s Establishment Inspection Report (EIR) for its Pithampur Unit-3 facility.
Establishment Inspection Report (EIR) | 06/11/2025 | By Dineshwori
NATCO Pharma's Kothur Facility Receives FDA EIR with VAI Classification
The US Food and Drug Administration (FDA) has completed an inspection at NATCO Pharma’s Pharma division located in Kothur, Hyderabad, India.
Establishment Inspection Report (EIR) | 18/09/2025 | By Dineshwori | 233
Alembic Pharmaceuticals Receives US FDA Compliance Report for Panelav API Facilities
Alembic Pharmaceuticals has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (US FDA) for the inspection conducted at its API-I and API-II facilities in Panelav, Gujarat.
Establishment Inspection Report (EIR) | 15/09/2025 | By Dineshwori | 206
Unichem Receives EIR with VAI Status from USFDA for Roha API Facility
Unichem Laboratories has announced that it has received an Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its Roha active pharmaceutical ingredients (API) facility.
Establishment Inspection Report (EIR) | 27/08/2025 | By Dineshwori | 155
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy